MAXHEALTH announced robust Q2 FY26 results, with revenue up 21% to ₹2,692 crore and net profit soaring 74.34% to ₹491.30 crore. The company's EBITDA margin improved to 26.93%. Expansion initiatives include new towers at Max Mohali, Nanavati-Max, and Max Smart, adding significant bed capacity. The company expects to benefit from CGHS price revisions, potentially adding over ₹200 crore to revenue once fully implemented.
Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations.
#StockInNews
814 likes·55 comments

















